New DNA nanomachine for rapid detection of HIV

Image
Press Trust of India Toronto
Last Updated : Oct 07 2015 | 1:57 PM IST
A nanoscale machine composed of synthetic DNA can be used for rapid, sensitive and low-cost diagnosis of many diseases, including HIV and rheumatoid arthritis, scientists say.
An international team of researchers has designed and synthetised a nanometer-scale DNA "machine" whose customised modifications enable it to recognise a specific target antibody.
The new approach may revolutionise the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV, researchers said.
The binding of the antibody to the DNA machine causes a structural change (or switch), which generates a light signal.
The sensor does not need to be chemically activated and is rapid - acting within five minutes - enabling the targeted antibodies to be easily detected, even in complex clinical samples such as blood serum.
"One of the advantages of our approach is that it is highly versatile," said senior co-author of the study Professor Francesco Ricci, of the University of Rome, Tor Vergata.
"This DNA nanomachine can be in fact custom-modified so that it can detect a huge range of antibodies, this makes our platform adaptable for many different diseases," Ricci said.
"Our modular platform provides significant advantages over existing methods for the detection of antibodies," added Professor Vallee-Belisle of the University of Montreal, the other senior co-author of the paper.
"It is rapid, does not require reagent chemicals, and may prove to be useful in a range of different applications such as point-of-care diagnostics and bioimaging," Vallee-Belisle said.
"Another nice feature of our this platform is its low-cost," said Professor Kevin Plaxco of the University of California, Santa Barbara.
"The materials needed for one assay cost about 15 cents, making our approach very competitive in comparison with other quantitative approaches," Plaxco said.
The research is published in the journal Angewandte Chemie.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 07 2015 | 1:57 PM IST

Next Story